ERIC 2018

The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October.

Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.

Projections from real world evidence of CLL management

Treatment-changing advancements in CLL: BTK, BCL-2, CD20 & CAR T-cells

Genomic discoveries in CLL

Richard Rosenquist

Opinion on MRD in CLL: routine use or clinical trials?

Resistance mechanisms in CLL

Richard Rosenquist

ERIC’s first International Meeting and plans for the future

Current ERIC research in the CLL genomics field

Richard Rosenquist

Prognostic markers and MRD in CLL

Current knowledge of the TP53 mutation and its role in CLL

Jitka Malčíková

Progress in CLL diagnosis and treatment

European Research Initiative on CLL (ERIC) International Meetings

Kostas Stamatopoulos

CLL cell dynamics

Nicholas Chiorazzi

An update on ERIC initiatives

CLL treatment duration and the role of MRD

Cell-extrinsic biomarkers for CLL: immunogenetic data

Andreas Agathangelidis

Cell-intrinsic biomarkers in CLL: focus on cytogenetics

1
2
3
4
Next